Table 1 Clinicopathologic features in patients with clinical stage III/N2 NSCLC
All patients (n = 84) | |
|---|---|
Age (median \(\pm\) SD) | 61.5 \(\pm\) 8.98 |
Gender (Male/ Female) | 57/27 |
Comorbidities | 59 (70.2%) |
FEV1 < 60% (n = 79a) | 9 (10.7%) |
Initial staging | |
- IIIA | 68 (81.0%) |
- IIIB | 16 (19.0%) |
Neoadjuvant Treatment | |
- CHT | 50 (60%) |
- CHT/RT | 34 (40%) |
Type of resection | |
- Pneumonectomy | 27 (32.2%) |
- Bilobectomy | 6 (7.1%) |
- Lobectomy | 50 (59.5%) |
- Segmental resection | 1 (1.2%) |
Extended resectionb | 37 (44.1%) |
Histological subtype | |
- Adenocarcinoma | 41 (48.8%) |
- Squamous cell carcinoma | 37 (44.0%) |
- Large cell carcinoma | 6 (7.2%) |
Pathological staging | |
- Complete response | 9 (10.7%) |
- I | 26 (31.0%) |
- II | 24 (28.6%) |
- III | 25 (29.8%) |
- IV | 0 (0%) |
N2 Downstaging (pN0-1) | 63 (75.0%) |
Postop. Complications (all) | 16 (19.0%) |
- Rec. nerve palsy | 6 (7.1%) |
- Chylothorax | 6 (7.1%) |
- Wound infection | 2 (2.4%) |
- Bleeding | 1 (1.2%) |
- Bronchopleural fistula | 0 (0%) |
- Other | 3 (3.6%) |
Adjuvant Treatment | 26 (31.0%) |
- aCHT | 17 (20.2%) |
- aRT | 4 (4.8%) |
- aCHT/RT | 5 (6.0%) |